your life science network cambridge healthtech...technologies, markets, and strategic issues driving...

RESEARCH • COLLABORAT ION • ADVANCEMENT

Cambridge Innovation InstituteCHI is a division of

Conference, Short Course, and Training Seminar CatalogSeptember 2018 – February 2019

Cambridge

HEALTHTECHInstitute

Cambridge

HEALTHTECHInstitute

Cambridge

HEALTHTECHInstitute

Your Life Science Netw

ork

Cam

brid

ge HEALTHTECH Institute

Your Life Science Netw

ork

Cam

brid

ge HEALTHTECH Institute

Your Life Science Network

2 | Cambridge Healthtech Institute

For over 25 years, Cambridge Healthtech Institute has developed more than 800 conferences, which have attracted over 60,000 attendees from around the world. CHI is the industry leader in offering quality programs that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments in the life science industry. Leading researchers and business experts from top pharmaceutical, biotech, and academic organizations present their most current findings in a forum that features panel discussions and audience participation.

Each year, CHI organizes over 170 annual events geared to the biotech and pharmaceutical industries with specific focuses on Biomarkers, Genomics, Proteins and Proteomics, Drug Discovery & Development, IT and Informatics, Chemistry, Diagnostics & Safety, and Business.

For a comprehensive listing and detailed information about our products and services, please visit: healthtech.com.

About Cambridge Healthtech Institute

Follow us

TABLE OF CONTENTS

CONFERENCE SERIESBiological Therapeutic Products ...................................................... 4Healthcare ....................................................................................... 4Biomarkers and Diagnostics ........................................................... 5Bioprocess and Manufacturing ....................................................... 5Clinical Trials & Translational Medicine ............................................ 6Chemistry ....................................................................................... 6BioPharmaceutical Strategy ............................................................ 7Drug Discovery & Development ..................................................... 7Detection ........................................................................................ 7Drug Targets .................................................................................... 8Genomics ........................................................................................ 8Informatics and IT ........................................................................... 8Therapeutic Indications ................................................................... 9Technology and Tools for Life Sciences ........................................... 9

CONFERENCES BY DATE WITH DETAIL .........................................10

SHORT COURSES AND TRAINING SEMINARS .............................11

CUSTOMER SERVICEPamela GerardiDirector of Customer ServiceE: [email protected] | T: 781-972-5409

Kris WatermanSr. Customer Service RepresentativeE: [email protected] | T: 781-972-5413

Rose LaRaiaCustomer Service RepresentativeE: [email protected] | T: 781-972-5400

MARKETINGJim MacNeilVice President of MarketingE: [email protected] | T: 781-972-5441

Rich HandySenior Director of MarketingE: [email protected] | T: 781-972-5456

SPONSOR & EXHIBIT SALESAngela ParsonsVice President of Business DevelopmentE: [email protected] | T: 781-972-5467

Joseph Vacca, M.S.,Director, Business DevelopmentE: [email protected] | T: 781-972-5431

GROUP SALES David CunninghamDirector, Inside SalesE: [email protected] | T: 781-972-5472

GRAPHICSThomas NortonDesign DirectorE: [email protected] | T: 781-972-5440

PRODUCTIONEdel O’ Regan, Ph.D.Vice President of ProductionE: [email protected] | T: 781-972-5423

Christina LinghamExecutive Director, Conferences and FellowE: [email protected] | T: 781-972-5464

Mary Ann BrownExecutive Director of ConferencesE: [email protected] | T: 781-972-5497

Julia Boguslavsky Executive Director of ConferencesE: [email protected] | T: 760-732-3139

Micah LiebermanExecutive Director of ConferencesE: [email protected] | T: 541-482-4709

Marina FilshtinskyExecutive Director of ConferencesE: [email protected] | T: 781-97205496

CONTACT US

@CHI_Healthtech

LinkedIn.com/company/Cambridge-Healthtech-Institute

Facebook.com/HealthtechConferences

YouTube.com/user/CambridgeHealthtech

Cambridge Healthtech Institute 250 First Avenue, Suite 300 | Needham, MA 02494

T: (781) 972-5400 or Toll-free in the U.S. 888-999-6288

F: (781) 972-5425

August 2018 – February 2019 | 3 www.healthtech.com

2019 KEY EVENTS

August 13-17, 2018Sheraton Boston

Boston, MA

BioprocessingSummit.com

Next GenerationSUMMIT

August 20-24, 2018Grand Hyatt Washington

Washington, DC

NextDenerationDx.com

Disc very

Disc veryDisc very

Disc very

TARGETonTARGETon

TARGETon TARGETon

September 25-28, 2018Sheraton Boston

Boston, MA

DiscoveryOnTarget.com

November 12-16, 2018Lisbon Congress Center

Lisbon, Portugal

Pegsummiteurope.com

PEPTALKTHE PROTEIN SCIENCE WEEK

January 14-18, 2019Hilton San Diego Bayfront

San Diego, CA

CHI-peptalk.com

February 18-21, 2019Hyatt Regency Orlando

Orlando, FL

SCOPEsummit.com

March 10-15, 2019Moscone South Convention Ctr

San Francisco, CA

Triconference.com

Drug DiscoveryChemistry

April 8-12, 2019San Diego Convention Center

San Diego, CA

Drugdiscoverychemistry.com

The Essential Protein Engineering Summit

April 8-12, 2019Seaport World Trade Center

Boston, MA

Pegsummit.com

ONE STOP SHOP AFFILIATED REPORTSCOLLECTION

for Over 2,000 Life Science Reports Spanning over 100 Research Areas

Insight Pharma Reports offers:

4 Market Data4 Pipeline Data4 Clinical Trial Data

4 Market Research4 Custom Reports4 Bundled Report Packages

For more information, contact Daniel Miller at: [email protected] or call (781) 972-5492

InsightPharmaReports.com

Just some of the Reports Available Include:

• Alzheimer’s Disease• Biomarkers & Diagnostics• BioPharma Strategy• Biosimilars & Generic Markets• Cancer Research and Therapeutics• Chemistry• Clinical Trials &

Translational Medicine

• Data Mining• Drug Discovery & Development• Health IT• Infectious Disease• Medical Devices• Multiple Sclerosis• Ocular• Pain Management• Pharmaceutical Marketing• Sequencing• Vaccines

...and many others

An Essential Collection of Timely & Concise Reports Analyzing the Technologies, Markets, and Strategic Issues Driving R&D Productivity. Available through Insight Pharma Reports and our Network of Affiliated Reports.

April 16-18, 2019Seaport World Trade Center

Boston, MA 02210

Bio-itworldexpo.com

WORLD PHARMA WEEK

June 17-21, 2019Seaport World Trade Center

Boston, MA


Conferences by Series

Biological Therapeutic Products

Constrained Peptides and MacrocyclicsSept. 26-27 • Boston, MA

Antibodies Against Membrane Protein Targets-Part 1Sept. 26-27 • Boston, MA

CNS and Neurodegenerative TargetsSept. 26-27 • Boston, MA

Antibodies Against Membrane Protein Targets-Part 2Sept. 26-27 • Boston, MA

Immunogenicity & Bioassay SummitOct. 22-25 • Alexandria, VA

Immunology for BiotherapeuticsOct. 22 • Alexandria, VA

Immunogenicity Assessment & Clinical RelevanceOct. 23-24 • Alexandria, VA

Immunogenicity Prediction and ControlOct. 24-25 • Alexandria, VA

Optimizing Bioassays for BiologicsOct. 24-25 • Alexandria, VA

PEGS Europe: Protein & Antibody Engineering SummitNov. 12-13 • Lisbon

Targeting the Tumor MicroenvironmentNov. 12-13 • Lisbon

Optimisation & DevelopabilityNov. 12-13 • Lisbon

Display of BiologicsNov. 12-13 • Lisbon

Next-Generation Antibody-Drug ConjugatesNov. 12-13 • Lisbon

Systems Engineering and Synthetic BiologyNov. 12-13 • Lisbon

Advancing Bispecifics and Combination Therapy to the ClinicNov. 14-15 • Lisbon

Optimising Expression PlatformsNov. 14-15 • Lisbon

Analytical Characterisation of BiotherapeuticsNov. 14-15 • Lisbon

Engineering AntibodiesNov. 14-15 • Lisbon

Winning Strategies for CAR T, TIL and TCR TherapyNov. 14-15 • Lisbon

Novel Therapies for Cancer and Emerging TargetsNov. 15-16 • Lisbon

Protein Aggregates & ParticlesNov. 15-16 • Lisbon

Agonist Immunotherapy Targets and Combination TherapiesNov. 15-16 • Lisbon

Optimizing Leads and Predicting Drug ToxicityNov. 28-29 • Lisbon

Optimizing Biologics Formulation DevelopmentJan. 14-15 • San Diego, CA

Engineering Genes, Vectors, Constructs, and ClonesJan. 14-15 • San Diego, CA

Advancing CNS Biotherapeutics and Crossing the Blood-Brain BarrierJan. 14-15 • San Diego, CA

Characterization of BiotherapeuticsJan. 14-15 • San Diego, CA

Bioprocess Data Management Jan. 14-15 • San Diego, CA

Lyophilization and Emerging Drying TechnologiesJan. 15-16 • San Diego, CA

Recombinant Protein Expression and ProductionJan. 15-16 • San Diego, CA

Computational and Analytical Tools for Protein EngineeringJan. 15-16 • San Diego, CA

Advances in Vector Production and Scale-Up for Cell and Gene TherapyJan. 15-16 • San Diego, CA

Detection and Characterization of Particulates and ImpuritiesJan. 15-16 • San Diego, CA

CHO Cell LinesJan. 16-17 • San Diego, CA

Protein Aggregation and Emerging Analytical ToolsJan. 17-18 • San Diego, CA

Optimizing Expression PlatformsJan. 17-18 • San Diego, CA

Deep Sequencing and Single Cell Analysis for Antibody DiscoveryJan. 17-18 • San Diego, CA

Antivirals: Targeting HBV and BeyondSept. 25 • Boston, MA

NASH and FibrosisSept. 26-27 • Boston, MA

Targeting the MicrobiomeSept. 27-28 • Boston, MA

Autoimmune and Inflammation Drug TargetsSept. 27-28 • Boston, MA

Leaders in BioBanking CongressOct. 14-16 • Cleveland, OH

Advances in Prenatal Molecular DiagnosticsOct. 29-30 • Cambridge, MA

Preclinical Models for Cancer Immunotherapy and CombinationsNov. 28-29 • Lisbon

NASH and Fibrosis: Translational Research and StrategiesNov. 28-29 • Lisbon

Biomarkers & Immuno-Oncology World CongressNov. 29-30 • Lisbon

Sensors for Healthcare Applications: Biosensors for Wearables & ImplantablesDec. 10-11 • San Diego, CA

Sensors for Emerging Applications: Smart Materials, Design & Engineering for WearablesDec. 11-12 • San Diego, CA

Implantable Biomedical Systems: Bioimplantable Device Design, Reliability, Wireless Charging & CommunicationsDec. 11-12 • San Diego, CA

Engineering Next-Generation Cancer immunotherapiesJan. 14-15 • San Diego, CA

Advancing CNS Biotherapeutics and Crossing the Blood-Brain BarrierJan. 14-15 • San Diego, CA



Summit for Clinical Ops Executives EuropeOct. 16-17 • Barcelona


Sensors for Emerging Applications: Smart MAterials, Design & Engineering for WearablesDec. 11-12 • San Diego, CA


Re-Entering Antibacterial Discovery and Development SummitSep. 25-28 • Boston, MA

Antibacterial Discovery and DevelopmentSep. 26-27 • Boston, MA

Protein Purification TechnologiesNov. 15-16 • Lisbon, Portugal

PepTalk-The Protein Science WeekJan. 14-18 • San Diego, CA

Optimizing Biologics Formulation DevelopmentJan. 14-15 • San Diego, CA


Characterization of BiotherapeuticsJan. 14-15 • San Diego, CA

Bioprocess Data ManagementJan. 14-15 • San Diego, CA

Lyophilization and Emerging Drying TechnologiesJan. 15-16 • San Diego, CA

Protein Purification and RecoveryJan. 15-16 • San Diego, CA


Advances in Vector Production and Scale-Up for Cell and Gene TherapyJan. 15-16 • San Diego, CA


Higher-Throughput Protein Production and CharacterizationJan. 17-18 • San Diego, CA

Protein Aggregation and Emerging Analytical ToolsJan. 17-18 • San Diego, CA


Microbial ProductionJan. 17-18 • San Diego, CA

Antiviral: Targeting HBV and BeyondSep. 25 • Boston, MA

Regenerative MedicineSep. 25 • Boston, MA

Re-Entering Antibacterial Discovery and Development SummitSep. 25-28 • Boston, MA

Antibacterial Discovery and DevelopmentSep. 26-27 • Boston, MA

NK Cell-Based Cancer ImmunotherapySep. 26-27 • Boston, MA

Constrained Peptides and MacrocyclicsSep. 26-27 • Boston, MA

NASH and FibrosisSep. 26-27 • Boston, MA

GPCR-Based Drug DiscoverySep. 26-27 • Boston, MA

Targeting Tumor Myeloid CellsSep. 27-28 • Boston, MA

Lead Generation StrategiesSep. 27-28 • Boston, MA

Autoimmune and Inflammation Drug TargetsSep. 27-28 • Boston, MA

Targeting Gram Negative PathogensSep. 27-28 • Boston, MA


Analytics-Driven Feasibility, Site Selection and Study ActivationOct. 16-17 • Barcelona

Patient-Centric Enrollment Planning and EngagementOct. 16-17 • Barcelona

Risk-Based Monitoring EuropeOct. 16-17 • Barcelona

Immunogenicity & Bioassay SummitOct. 22-25 • Alexandria, VA

Immunogenicity Assessment & Clinical RelevanceOct. 23-24 • Alexandria, VA

Optimizing Bioassays for BiologicsOct. 24-25 • Alexandria, VA

Executive Decision MakingOct. 22-26 • Philadelphia, PA

Strategic Resource ManagementOct. 22-23 • Philadelphia, PA

Portfolio ManagementOct. 22-23 • Philadelphia, PA

Summit for Clinical Ops Executives (SCOPE)Feb. 18-21 • Orlando, FL

Protocol Development, Global Site Selection, Feasibility and Site ManagementFeb. 19-20 • Orlando, FL

Enrollment Planning and Patient RecruitmentFeb. 19-20 • Orlando, FL


Conferences by SeriesClinical Trial Forecasting, Budgeting and ContractingFeb. 19-20 • Orlando, FL

Mastering an Outsourcing StrategyFeb. 19-20 • Orlando, FL

Implementing Risk-Based Monitoring – Part 1Feb. 19-20 • Orlando, FL

Clinical Data Strategy and AnalyticsFeb. 19-20 • Orlando, FL

Sensors, Wearables and Digital Biomarkers in Clinical TrialsFeb. 19-20 • Orlando, FL

Late Stage Research Strategy and OperationsFeb. 19-20 • Orlando, FL

Clinical Biomarkers Strategy and InnovationFeb. 19-20 • Orlando, FL

Clinical Supply ManagementFeb. 19-20 • Orlando, FL

Improving Site-Study Activation and PerformanceFeb. 20-21 • Orlando, FL

Patient Engagement, Enrollment and Retention through Communities and TechnologyFeb. 20-21 • Orlando, FL

Resource Management and Capacity Planning for Clinical Trials Feb. 20-21 • Orlando, FL

Managing Outsourced Clinical TrialsFeb. 20-21 • Orlando, FL

Implementing Risk-Based Monitoring – Part 2Feb. 20-21 • Orlando, FL

Artificial Intelligence in Clinical ResearchFeb. 20-21 • Orlando, FL

Clinical Technology and InnovationFeb. 20-21 • Orlando, FL

Leveraging RWD for Clinical and Observational ResearchFeb. 20-21 • Orlando, FL

Clinical Biospecimens and Central Lab SolutionsFeb. 20-21 • Orlando, FL

Targeting Autophagy Sep. 25 • Boston, MA

Antivirals: Targeting HBV and BeyondSep. 25 • Boston, MA

Targeting the Ubiquitin-Protoeasome SystemSep. 26-27 • Boston, MA

Kinase Inhibitor ChemistrySep. 26-27 • Boston, MA

Small Molecules for Cancer ImmunotherapySep. 26-27 • Boston, MA

Constrained Peptides and MacrocyclicsSep. 26-27 • Boston, MA

NASH and Fibrosis Sep. 26-27 • Boston, MA

Kinase Inhibitor DiscoverySep. 27-28 • Boston, MA

GCPR-Based Drug DiscoverySep. 27-28 • Boston, MA

Lead Generation Strategies Sep. 27-28 • Boston, MA

Autoimmune and Inflammation Drug TargetsSep. 27-28 • Boston, MA

World Preclinical Congress EuropeNov. 27-30 • Lisbon

Lead Generation StrategiesSep. 27-28 • Boston,MA


Immunogenisity Assessment & Clinical RelevanceOct. 23-24 • Alexandria, VA

Immunogenicity Prediction and ControlOct. 24-25 • Alexandria, VA

Executive Decision MakingOct. 22-26 • Philadelphia, PA

Strategic Resource ManagementOct. 22-23 • Philadelphia, PA

Portfolio ManagementOct. 23-24 • Philadelphia, PA

Strategic and Operational Challenges of Oncology and Immuno-Oncology Drug DevelopmentOct. 25-26 • Philadelphia, PA

Project Portfolio Management Master ClassOct. 25-26 • Philadelphia, PA

Single-Cell-AnalysisNov. 27 • Lisbon

CNS Models and Translational StrategiesNov. 29-30 • Lisbon

Strategic Alliance Management Congress EuropeDec. 4-5 • Lisbon


Bioprocess Data ManagementJan. 14-15 • San Diego, CA





Discovery on TargetSep. 25-28 • Boston, MA

Targeting AutophagySep. 25 • Boston, MA

Regenerative MedicineSep. 25 • Boston, MA

Targeting the Ubiquitin-Proteasome SystemSep. 26-27 • Boston, MA

Antibodies Against Membrane Protein Targets-Part 1Sep. 26-27 • Boston, MA

CNS and Neurodegenerative TargetsSep. 26-27 • Boston, MA

Antibody Discovery Forum-Part 1Sep. 26-27 • Boston, MA



Conferences by SeriesTargeting Tumor Myeloid CellsSep. 27-28 • Boston, MA


Antibody Discovery Forum-Part 2Sep. 27-28 • Boston, MA Immunogenicity Assessment & Clinical RelevanceOct. 23-24 • Alexandria, VA

IDisplay of BiologicsNov. 12-13 • Lisbon

Next-Generation Antibody-Drug ConjugatesNov. 12-13 • Lisbon

Advancing Bispecifics and Combination Therapy to the ClinicNov. 14-15 • Lisbon

Winning Strategies for CAR T, TIL and TCR TherapyNov. 14-15 • Lisbon

Engineering BispecificsNov. 15-16 • Lisbon

Novel Therapies for Cancer and Emerging TargetsNov. 15-16 • Lisbon

World Preclinical Congress EuropeNov. 27-30 • Lisbon

Artificial Intelligence & Machine Learning for Drug DiscoveryNov. 27 • Lisbon

PepTalk-The Protein Science WeekNov. 28-29 • Lisbon

Translational Biomarkers in Immuno-OncologyNov. 29-30 • Lisbon

Induced Pluripotent Stem CellsNov. 29 • Lisbon

Recombinant Protein TherapeuticsJan. 14-15 • San Diego, CA

Antibody-Drug ConjugatesJan. 15-16 • San Diego, CA

Higher-Throughput Protein Production and CharacterizationJan. 17-18 • San Diego, CA

Bispecific Antibody TherapeuticsJan. 17-18 • San Diego, CA

Deep Sequencing and Single Cell Analysis for Antibody DiscoveryJan. 17-18 • San Diego, CA

Sensors SummitDec. 10-12 • San Diego, CA


Sensors for Emerging Applications: Smart Materials, Design & Engineering for WearablesDec. 11-12 • San Diego, CA


Detection and Characterization of Particulates and ImpuritiesJan. 15-16 • San Diego, CA

Drug TargetsSERIES

Discovery on TargetSep. 25-28 • Boston, MA

NK Cell-Based Cancer ImmunotherapySep. 26-27 • Boston, MA

Small Molecules for Cancer ImmunotherapySep. 26-27 • Boston, MA



Target Identification & Validation-Part 1Sep. 26-27 • Boston, MA


Targeting the MicrobiomeSep. 27-28 • Boston, MA


Targeting Tumor Myeloid CellsSep. 27-28 • Boston, MA



Targeting Gram Negative PathogensSep. 27-28 • Boston, MA


Leaders in BioBanking CongressOct. 14-16 • Cleveland, OH

Targeting the Tumor MicroenvironmentNov. 12-13 • Lisbon

Engineering AntibodiesNov. 14-15 • Lisbon

Engineering BispecificsNov. 15-16 • Lisbon

Agonist Immunotherapy Targets and Combination TherapiesNov. 15-16 • Lisbon

Artificial Intelligence & Machine Learning for Drug DiscoveryNov. 27 • Lisbon

Preclinical Models for Cancer Immunotherapy and CombinationsNov. 28-29 • Lisbon

Target Identification & Validation StrategiesNov. 28-29 • Lisbon

NASH and Fibrosis: Translational Research and StrategiesNov. 28-29 • Lisbon

Translational Biomarkers in Immuno-OncologyNov. 29-30 • Lisbon

CNS Models and Translational StrategiesNov. 29-30 • Lisbon

Engineering Next-Generation Cancer ImmunotherapiesJan. 14-15 • San Diego, CA






Advances in Prenatal Molecular DiagnosticsOct. 29-30 • Cambridge, MA

Target Identification & Validation StrategiesNov. 28-29 • Lisbon

Microbial ProductionJan. 17-18 • San Diego, CA


Analytics-Driven Feasibility, Site Selection and Study ActivationOct. 16-17 • Barcelona

Patient-centric Enrollment Planning and EngagementOct. 16-17 • Barcelona

Risk-Based Monitoring EuropeOct. 16-17 • Barcelona

Executive Decision MakingOct. 22-26 • Philadelphia, PA.

Strategic Resource ManagementOct. 22-23 • Philadelphia, PA.

Portfolio ManagementOct. 23-24 • Philadelphia, PA.

Strategic and Operational Challenges of Oncology and Immuno-Oncology Drug DevelopmentOct. 25-26 • Philadelphia, PA.

Project Portfolio Management Master ClassOct. 25-26 • Philadelphia, PA.

Organ-on-a-Chip and MicroPhysiological SystemsNov. 27 • Lisbon

Single-Cell-AnalysisNov. 27 • Lisbon

AI World Conference & ExpoDec. 3-5 • Boston, MA

Enterprise AI Case StudiesDec. 4 • Boston, MA

Going from Big Data to AIDec. 4 • Boston, MA

AI & Real-Time IoTDec. 4 • Boston, MA

AI in HealthcareDec. 4 • Boston, MA

AI in PharmaDec. 4 • Boston, MA

Emerging Technologies & the Future of AIDec. 5 • Boston, MA

Cognitive Aware RobotsDec. 5 • Boston, MA

AI in Healthcare IIDec. 5 • Boston, MA

AI in Pharma IIDec. 5 • Boston, MA

Computational and Analytical Tools for Protein EngineeringJan. 15-16 • San Diego, CA


SERIESOrgan-on-a-Chip and MicroPhysiological SystemsNov. 27 • Lisbon

3D Cellular ModelsNov. 29-30 • London, United Kingdom

Recombinant Protein TherapeuticsJan. 14-15 • San Diego, CA

Optimisation & DevelopabilityNov. 12-13 • Lisbon

Systems Engineering and Synthetic BiologyNov. 12-13 • Lisbon

Optimising Expression PlatformsNov. 14-15 • Lisbon

Analytical Characterisation of BiotherapeuticsNov. 14-15 • Lisbon


Conferences by Date with DetailDiscovery On TargetSeptember 25-28, 2018 • Boston, MAThe 16th Annual Discovery on Target, “The Industry’s Preeminent Event on Novel Drug Targets,” will once again gather over 1,300 drug discovery professionals in Boston, MA, this September 25-28, 2018. The event brings forth current and emerging “hot” targets, technolo-gies and validation strategies for the development of novel small mol-ecules and biologics.DiscoveryOnTarget.com

Leaders in Biobanking CongressOctober 14-16, 2018 • Cleveland, OHCambridge Healthtech Institute’s Tenth International Leaders in Biobanking Congress addresses innovations in biospecimen science and infrastructure to support expanding applications. Maintaining the integrity of biospecimens allows biomedical and biopharmaceutical researchers, regulators, biorepository managers, and practitioners to investigate the best strategies for effective use of biospecimens within today’s cutting-edge biomedical research.BiobankingCongress.com

Summit for Clinical Ops Executives Europe October 16-17, 2018 • Barcelona, SpainBuilding on the success of its long-running US-based counterpart, Summit for Clinical Trials Operations Executives Europe (SCOPE Europe) is a two-day event serving clin ops execs, functional heads, category managers and those responsible for the planning and man-agement of clinical trials in Europe and the Rest of the World. The event will feature opening and closing plenary keynote sessions, three conference tracks, interactive breakout discussion groups and networking. It is an opportunity for leaders from large, mid-sized, and small pharma, specialty pharma, biotech, vendor companies, and academic research centers to come together to share best practices and discuss the new era of analytics-driven and patient-centric trials. Topics to be discussed include protocol development, global site se-lection, feasibility, site management, patient engagement, enrollment planning, patient recruitment, patient retention, improving site-study activation and performance, functional/full-service outsourcing and partnerships, new regulations and guideline, Risk-Based Monitoring (RBM), and improving overall quality and speed of clinical trials.ScopeSummitEurope.com

Immunogenicity & Bioassays Summit October 22-25, 2018 • Alexandria, VANow in its 10th year, CHI’s Immunogenicity & Bioassay Summit will examine the challenges currently facing the industry and will provide NEW case studies, NEW perspectives and NEW approaches. You will hear from the industry, academia and the regulatory authorities. This year we present 3 Conference Programs, a Symposium, Training Seminar and many short courses for in-depth study, as well as inter-active breakout discussions for sharing of experiences and ideas, and excellent networking opportunities.ImmunogenicitySummit.com

Executive Decision Making October 22-26, 2018• Philadelphia, PACambridge Healthtech Institute’s annual executive forum brings together R&D executives from the biopharma community to share best practices in project and portfolio management, R&D innovation, decision analysis, forecasting, resource management and immuno-oncology drug development. Delegates will gain strategic insights, proven tools, methods, and perspectives from a variety of leaders at the intersection of science, business and operations.ExecutiveDecisionMaking.com

Advances in Prenatal Molecular Diagnostics October 29-30, 2018 • Cambridge, MACell-free DNA-based screening and the potential for cell-based screening has upended the field of prenatal testing. While cell-free tests are being used more and more in the clinic, cell-based tests are still on the cusp of commercialization. With both types of tests still in need of improvements in order to truly replace invasive tests, the near-term challenge is determining where the field heads once both options are viable. This meeting will discuss updated comparisons and examine the implementation, insurance, and clinical challenges associated with each test.Prenatal-DX.com

Paws for a Cure Research Symposium November 12-13, 2018 • Boston, MAAdvancing research in pediatric cancer treatments has unique chal-lenges, and progress toward better medicines and a cure has been limited. Intriguingly, BOTH children and our canine companions spontaneously develop a number of cancers with remarkable similari-ties, including osteosarcoma, certain brain/CNS cancers, lymphoma and leukemia. Speakers, panelists and participants will discuss chal-lenges and progress in accelerating cancer drug development using comparative approaches.PawsForACureSymposium.com

Protein & Antibody Engineering Summit Europe November 12-16, 2018 • Lisbon, PortugalPEGS Europe is the largest European event covering all aspects of protein and antibody engineering. In 2017, for the sixth year in a row, a record number of delegates participated in PEGS Europe, as more than 900 attendees from 35 countries convened in beauti-ful Lisbon, Portugal to discuss the latest advances in protein and antibody engineering.PEGSummitEurope.com


Conferences by Date with DetailWorld Preclinical Congress EuropeNovember 27-30, 2018 • Lisbon, PortugalFor 17 years the World Preclinical Congress has built its niche and expertise around bringing together scientists from academia and pharma/biotech companies involved in drug discovery. In recent years it has focused predominantly on preclinical research, highlighting the various challenges and opportunities that exist in early drug discovery and development. World Preclinical Congress Europe will continue to build on this mission by providing a unique opportunity for scientists and technology providers to share ideas and collaborate to accelerate preclinical work. The venue in Lisbon, Portugal provides an ideal, infor-mal setting for experts based in the European Union to network with their global counterparts to build a strong and diverse community to transform preclinical drug discovery.WorldPreclinicalEurope.com

Strategic Alliance Management Congress EuropeDecember 3-5, 2018 • Lisbon, PortugalAs the biopharmaceutical industry continues to rely on alliances and collaboration with external organizations to access innovation and obtain market access, internal teams are often confronted with the increasing complexities of systematically and effectively managing partnerships throughout their lifecycle. The function and organizational capability of Alliance Management is now recognized as a critical means to ensure the successful execution of any strategic partner-ship, acting as a central driver of value, while alleviating perturbations, and meeting alliance goals.Healthtech.com/Alliance-Europe

Sensors Summit December 10-12, 2018 • San Diego, CAEmerging technological innovations enabled by next generation sen-sors will define the landscape for the future commercialization of life changing products. The exponential growth of the global sensors market and the demand for next generation integrated systems is ex-pected to reach $154 billion by 2020. Our international faculty of key industry and academic leaders will present the latest technological advancements of real-world applications within healthcare and emerg-ing markets through our conference tracks, symposium and tutorials.SensorsGlobalSummit.com

PepTalk: The Protein Science WeekJanuary 14-18, 2019 • San Diego, CAPepTalk: The Protein Science Week is one of the largest annual gath-erings of protein science researchers in the world. Now, in its 18th year, PepTalk features renowned speakers from academia, biotech and pharma who bring global expertise and perspective to the fore-front. The international delegation of over 1,300 participants convene for intensive learning and networking to discover new opportunities, apply alternative solutions, and develop promising partnerships.CHI-PepTalk.com

SCOPE - Summit for Clinical Ops ExecutivesFebruary 18-21, 2019 • Orlando, FLCelebrating its 10th successful year, SCOPE Summit 2019 takes place February 18-21 in Orlando, FL. Over the course of four stimu-lating days of in-depth discussions in 18 different conferences, 3 plenary keynote sessions, and the ever-popular interactive breakout discussions, the programming focuses on advances and innova-tive solutions in all aspects of clinical trial planning, management and operations, including: Site Selection and Management, Patient Engagement, Recruitment and Retention, Protocol Optimization, Feasibility, Data Strategy & Analytics, Sensors and Wearables, Project Management, Outsourcing, Forecasting, Budgeting and Contracting, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Post-Marketing Studies, Observational Research, Clinical Biomarker Strategy, Clinical Supply Chain, Precision Medicine, and Biospecimens and Central Lab Solutions.ScopeSummit.com

Connecting clients with core clinical research training solutions and resources.

CONNECTING LEARNING TO CLINICAL RESEARCH OUTCOMES

• Live & Web-Based Seminars • Custom Programs & Services• Publications & Job Aides BarnettInternational.com


Short Courses and Training SeminarsSC = Short Course | TS = Training Seminar

Discovery On TargetSeptember 25-28, 2018 • Boston, MA

SC1: Introduction to GPCR-Based Drug Discovery

SC2: Drug Metabolism and Its Role in Discovery and Drug Development

SC3: How to Best Utilize 3D Cells, Spheroids and PDX Models in Oncology

SC4: Covalent Fragments: Applications in Target-Based and Phenotypic Screens

SC7: Enabling Macrocyclic Compounds for Drug Discovery

SC8: Targeting of Ion Channels with Monoclonal Antibodies

SC9: CNS Translational Strategies

SC10: Applications of Artificial Intelligence and Machine Learning in Drug Discovery and Development

SC11: Mechanistic Understanding of Pharmacological Probes for the Ubiquitin-Proteasome System

SC12: Clinically Relevant Animal Modeling for the Evaluation of Novel Antibacterial Approaches

SC13: GPCR Structure-Based Drug Discovery

SC14: Advancing Tools and Technologies for Fragment-Based Design

SC15: Introduction to Targeted Covalent Inhibitors

SC16: Immunology Basics

SC17: Technologies to Assess Permeability and Efflux in Gram-Negative Bacterial Pathogens

SC18: Practical Phenotypic Screening

TS1: Machine Learning for Effective Drug Discovery Decisions

TS2: Introduction to Small Molecule Drug Discovery and Development

Leaders In Biobanking Congress October 14-16, 2018 • Cleveland, Ohio

SC1: Lean Six Sigma and the Biorepository

SC2: CAP Biorepository Accreditation Program

Immunogenicitiy & Bioassays SummitOctober 22-25, 2018 • Alexandria, VA

SC1: Mechanism of Action and Risk-Based Approach for Developing Neutralizing Ab Assays

SC2: Overcoming Drug Target Interference in ADA Assays

SC3: Validation of ADA Assays and Cut Point Calculations

SC4: Immunology for Immuno-Oncology

SC5: Back to Basics: Optimizing Bioassay Design and Analysis

SC6: Advice on Putting Together an Integrated Summary of Immunogenicity

TS1: Introduction to Design of Experiments

PEGS Europe: Protein & Antibody Engineering SummitNovember 12-16, 2018 • Lisbon, Portugal

SC1: Transient Protein Expression: A Key Tool to Enable Rapid Protein Engineering

SC2: Making Antibody Libraries in Phage and Yeast

SC3: Introduction to the Tumour Microenvironment and Response to Cancer Immunotherapy

SC4: Mutation and Selection Strategies Beyond Affinity Optimisation

SC5: Surfactants in Biotherapeutics: Can’t Live with Them, Can’t Live without them

SC6: Fast Modelling of Protein and Nucleic Acid Structure and Dynamics - A Hands-On Introduction to MacroMoleculeBuilder

SC7: Protein Aggregation: Mechanism, Characterisation and Consequences

SC8: Selection, Screening and Engineering for Affinity Reagents

SC9: Optimising Protein Purification Strategies in Advance: Getting Your Plan Right

SC10: Engineering of Bispecific Antibodies

TS6A: Basic Technologies in a Protein Production Lab

TS7A: Introduction to Bispecifics: History, Engineering and Application

TS8A: Introduction to Protein Engineering

TS6B: Rational Approaches to Biologics Formulation & Delivery

TS7B: Next-Generation Sequencing for Antibody Discovery & Engineering

TS6C: Potency and Comparability for Cell and Gene Products

TS7C: Introduction to CAR-T Engineering for Protein Scientists

World Preclinical Congress EuropeNovember 27-30, 2018 • Lisbon, Portugal

SC1: Immunology Basics for Drug Discovery, Part 1: Immune System Overview

SC2: Understanding Key Concepts in Drug Metabolism and Drug Transport

SC3: The Origins, Optimization and Application of Organ-on-a-Chip Systems)

SC4: Immunology Basics for Drug Discovery, Part 2: Immune-Oncology and Autoimmunity

SC5: Humanized Mouse Models: Technology and Applications in Preclinical Assessment of Cancer Immunotherapy

PepTalk: The Protein Science WeekJanuary 14-18, 2019 • San Diego, CA

SC1: Characterization and Analysis of Particulates

SC2: Protein Crystallization-Delineating Protein Structure

SC3: DoE and QbD: Tools for Optimizing the Bioprocess

SC4: Dynamic Light Scattering-Theory, Do’s & Don’ts and Data Interpretation

SC5: De-risking Your Pipeline

SC6: Affecting Effector Functions to Optimize the Efficacy of Therapeutic Antibodies

SC7: Rational Design of Protein Solutions

LEAD GENERATION

LIFE SCIENCE

PROGRAMS

Cambridge Healthtech Institute’s

Healthtech.com/Lead-Gen

Content marketing designed to fill your pipeline with targeted leads!

WebinarsWhitepapersMarket ResearcheBooksPodcasts

Increase your Sales Revenue with

CHI is a division of Cambridge Innovation Institute

CHI

Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, CROs, academia, and niche service providers. CHI is renowned for its vast conference portfolio held worldwide including PepTalk, Molecular Medicine Tri-CON, SCOPE Summit, Bio-IT World Conference & Expo, PEGS Summit, Drug Discovery Chemistry, Biomarker World Congress, World Pharmaceutical Congress, Next Generation Dx Summit and Discovery on Target.

About Cambridge Healthtech InstituteYour Life Science Network

healthtech.com250 First Avenue, Suite 300

Needham, Massachusetts 02494

USA Phone: 781.972.5400

Additional divisions of CHI include

healthtechpublishing.com

insightpharmareports.com

barnettinternational.com

your life science network cambridge healthtech...technologies, markets, and strategic issues driving...

Documents